GLP-1 for Competition Prep: Physique & Figure Athletes

Introduction

Bodybuilding prep is the one context where appetite-suppressing drugs feel almost too useful. The athlete already eats clean, trains hard, and tracks every gram. The problem is the last 10 pounds, where leptin tanks, hunger explodes, and 1,500-calorie days start feeling impossible. GLP-1 agonists like semaglutide and tirzepatide can quiet that hunger, but they bring a real cost: muscle preservation is the entire point of contest prep, and these drugs cause meaningful lean mass loss alongside fat.

Physique federations don’t ban GLP-1s. They’re not on the WADA prohibited list, and natural organizations like the INBF, OCB, and ANBF don’t list them either. That doesn’t mean using one is smart. The dosing strategies, timing, and risks for competitive athletes look almost nothing like the standard obesity protocol, and most coaches are still learning what works.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Are GLP-1s Legal in Physique and Figure Competition?

Yes, in every major federation as of 2026. WADA’s prohibited list, which most drug-tested federations reference directly or modify, doesn’t include semaglutide, tirzepatide, liraglutide, or any other GLP-1 receptor agonist. The INBF/WNBF, OCB, ANBF, NPC, and IFBB Pro League also don’t list them in their banned substances documentation.

Quick Answer: GLP-1s are not banned by WADA, the IFBB Pro League, or major natural federations as of 2026

That said, federation rules change. Athletes should pull the current banned-substance list from their specific federation within 30 days of the show. Some natural federations ban any prescription drug used for weight loss purposes under broad “performance enhancing” language, even if not named. Read the rules.

GLP-1s also won’t show up on a standard urine polygraph because they’re peptide hormones in a class that isn’t tested for. The drug is detectable in plasma but not in the panels federations actually run.

How Much Muscle Do You Lose on a GLP-1?

In STEP 1, the major semaglutide obesity trial (Wilding et al. 2021 NEJM), participants lost 14.9% of body weight at 68 weeks. DEXA substudy data published later showed roughly 39% of that loss was lean mass, with about 61% from fat. That’s actually similar to other diet-only weight loss interventions in untrained populations, but it’s a serious problem for someone who’s already lean and trying to get leaner.

SURMOUNT-1 (Jastreboff et al. 2022 NEJM) tested tirzepatide and saw 20.9% mean weight loss at 72 weeks on the 15 mg dose. Body composition substudies showed a similar ratio. Heymsfield et al. 2024 published a SURMOUNT-1 body comp analysis in Nature Medicine confirming around 25 to 30% of total loss was lean mass on the highest tirzepatide dose.

For a 180-pound figure competitor with 18% body fat trying to get to 12%, this matters enormously. The difference between losing 3 pounds of muscle versus 6 pounds during prep can be the difference between a callout spot and missing first cut.

Can Resistance Training Offset the Muscle Loss?

Partially, but probably not fully at high doses. The trials cited above didn’t require lifting, and most participants were untrained. A 2024 Diabetes, Obesity and Metabolism review by Conte et al. summarized the limited resistance training data and concluded that high-protein intake plus structured lifting attenuates but doesn’t eliminate the lean mass penalty.

Practical prep numbers: 1.0 to 1.2 grams of protein per pound of body weight, four to six hard lifting sessions weekly, and a deficit no steeper than 1% of body weight per week. The hunger suppression from a GLP-1 can make hitting protein targets harder, which is the opposite of what a competitor needs. Some athletes find themselves at 80 grams of protein on a day they planned for 200 because food is genuinely unappealing.

This is the strongest argument against GLP-1s in prep. The drug works by making you not want to eat. The athlete’s job is to eat exactly the right amount.

What Dose Makes Sense for a Physique Athlete?

Most prep coaches who use GLP-1s use micro-doses well below the FDA-approved obesity range. Standard semaglutide titration goes 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg weekly across 16 weeks. A physique athlete typically starts at 0.1 to 0.25 mg and stays there.

The reasoning: the athlete isn’t trying to lose 20% body weight. They need a 5 to 10% deficit-induced loss across 16 to 20 weeks, with hunger control to make the last weeks tolerable. A 0.25 mg dose suppresses ghrelin response and slows gastric emptying enough to blunt hunger without crashing appetite to zero. TrimRx’s clinical team sees most competitive prep clients in the 0.1 to 0.5 mg semaglutide range, never near the 2.4 mg obesity dose.

Tirzepatide micro-dosing follows similar logic: 1.25 to 2.5 mg weekly rather than the 10 to 15 mg used for obesity. Less data exists on this approach, and it’s all anecdotal from coaches and clinicians.

When Should an Athlete Stop the Drug Pre-show?

Four to eight weeks out is the common window. Semaglutide has a half-life of about 7 days, so it takes roughly 5 weeks (5 half-lives) to clear to negligible levels. Tirzepatide has a similar 5-day half-life. Stopping 6 weeks pre-show puts the athlete at functional baseline by show week.

Why it matters: peak week involves carb loading, sodium manipulation, and water cuts. All three require a normal GI system. Delayed gastric emptying from residual drug can blunt the carb-load fill, leave the athlete flat, and make water cuts unpredictable. Some athletes report feeling “smooth” and unable to glycogen-load on drug.

Also relevant: rebound hunger after stopping. The first 2 to 3 weeks off the drug typically include strong appetite rebound. Building this into prep means the last refeed days and the final push happen when hunger is back online, which is what you want for adherence to a structured carb load.

What Are the Risks Specific to a Contest-prep Diet?

Two big ones: dehydration and electrolyte imbalance. Athletes already restrict water for the final 24 to 48 hours pre-stage. GLP-1s slow gastric emptying and can worsen the sensation of fullness and nausea, particularly when combined with diuretics. Cases of severe dehydration and acute kidney injury have been reported in non-athlete users, though they’re rare.

The second risk is hypoglycemia, especially for athletes also using insulin or insulin sensitizers like metformin. GLP-1s alone rarely cause low blood sugar in non-diabetics, but combining with other glucose-lowering agents can. A pre-stage athlete eating 50 grams of carbs across a 12-hour day is already glucose-restricted.

Pancreatitis is a known GLP-1 risk and physique athletes sometimes use other drugs (clenbuterol, T3, fat burners) that can stack metabolic stress. The IFBB has lost competitors to cardiac events linked to drug stacking. Adding a GLP-1 to that mix without medical oversight is reckless.

Key Takeaway: Tirzepatide produced 20.9% mean weight loss at 72 weeks in SURMOUNT-1 (Jastreboff et al. 2022 NEJM), with similar lean mass concerns

How Does This Compare to Clenbuterol or T3?

Clenbuterol is a beta-2 agonist that raises metabolic rate and is famously catabolic in higher doses. It’s banned by WADA and most natural federations. T3 (synthetic thyroid hormone) is also banned by some federations and causes substantial muscle loss when used aggressively. Both work by raising energy expenditure.

GLP-1s work the opposite way: they reduce energy intake by suppressing hunger. The lean mass cost is real but the mechanism is different. For a natural athlete who’s banned from clen and T3, a micro-dosed GLP-1 might be a legal alternative for the same end goal (last-mile leanness without a stimulant load). For an enhanced athlete already using clen or thyroid, stacking a GLP-1 on top is stacking GI side effects on top of cardiac stress.

The honest answer: no drug makes contest prep easy. Each one trades something for something else.

Can Female Figure and Bikini Competitors Use GLP-1s Safely?

Yes, with the same caveats as male competitors plus a few extras. Female prep typically runs longer (20 to 24 weeks) at smaller calorie deficits because female metabolic adaptation is severe and amenorrhea is common. GLP-1s can help maintain a small deficit across that longer window.

The extras: pregnancy must be ruled out before starting and prevented throughout. GLP-1s aren’t proven safe in pregnancy and the FDA recommends stopping at least 2 months before attempting conception. Most female competitors are on hormonal contraception or use barrier methods, but the absorption of oral contraceptives can be affected by GLP-1-induced gastric slowing, particularly in the first 4 weeks after a dose increase. Backup contraception is recommended during titration.

Female competitors also tend to have lower muscle mass reserves to begin with, making the lean mass penalty more consequential as a percentage of total mass.

What Does the Assessment Look Like for an Athlete?

TrimRx’s free assessment quiz screens for the standard contraindications: personal or family history of medullary thyroid carcinoma, MEN-2 syndrome, prior pancreatitis, severe gastroparesis, current pregnancy. For competitive athletes, the additional screening should cover federation rules, current PED use, and bloodwork showing baseline thyroid, kidney, and liver function.

The personalized treatment plan for an athlete typically pairs a micro-dose protocol with structured macros, scheduled refeeds, and a clear stop-date relative to the show. This is not a cookie-cutter obesity protocol. Athletes who try to use the standard titration end up under-eating, under-recovering, and walking on stage flat.

What Do I Do If I Get a “Drug-tested Show” Notice?

Pull the federation’s current banned list and check it word-for-word. Most natural federations test by polygraph, urine, or both. As of 2026, no major federation tests urine for GLP-1 peptides. WADA’s panel doesn’t include them either.

That said: if the federation has a “spirit of the rules” clause or includes prescription weight-loss drugs broadly, declaring use to the federation in advance is the right move. Some federations will allow with a TUE (therapeutic use exemption) if the athlete has documented medical need. Most natural physique federations would deny a TUE for purely competitive use.

If polygraph testing is involved, telling the truth is the only viable strategy. Lying on a poly is how people get caught and stripped.

Bottom line: Stopping the drug 4 to 8 weeks pre-show is common practice to allow appetite return for refeeds and water manipulation

FAQ

Will a GLP-1 Show up on a Federation Drug Test?

No standard federation drug panel as of 2026 tests for semaglutide, tirzepatide, or other GLP-1 receptor agonists. The drugs are peptide hormones detectable in plasma with specialized assays but not in routine urine screens used by WADA or natural federations. Polygraph testing is a separate question; answering truthfully matters there.

How Much Weight Should I Expect to Lose on a Micro-dose?

At 0.1 to 0.25 mg semaglutide weekly across 16 to 20 weeks of structured prep, most athletes see 0.5 to 1% body weight loss per week, similar to a standard contest-prep diet without drug. The drug’s value isn’t extra fat loss; it’s hunger management during the last 6 weeks when willpower runs out.

Should I Take Creatine While on a GLP-1?

Yes. Creatine monohydrate at 3 to 5 grams daily helps preserve lean mass during caloric restriction and is well-studied in dieting athletes. It also helps maintain performance in the gym, which protects training stimulus. The drug doesn’t interact with creatine. Stop creatine at the same time as standard peak-week protocol (typically 1 to 2 weeks out depending on water plan).

Can I Use a GLP-1 in the Off-season?

This is harder to justify. Off-season is muscle-building season; appetite suppression works against the goal. Some athletes use micro-doses during a short mini-cut between prep and off-season to bridge the gap without losing too much hard-earned tissue, but using a GLP-1 across a 6-month mass phase makes no sense.

What If I’m an Enhanced Lifter Already on Testosterone or AAS?

Anabolic steroid use partially offsets the lean mass loss from caloric restriction but doesn’t eliminate it. An enhanced athlete using a GLP-1 will still lose less muscle than a natural one but more than they would without the drug. The bigger concern is stacking drugs that all affect cardiac and metabolic stress.

Does Insurance Cover GLP-1s for Physique Prep?

No. Insurance covers GLP-1s for type 2 diabetes (with prior auth) and increasingly for obesity at BMI 30 or 27 with comorbidity. A lean physique athlete with a BMI of 23 won’t qualify. Cash-pay through a telehealth platform like TrimRx is the typical route, with compounded semaglutide running roughly $200 to $400 per month depending on dose.

What’s the Muscle Loss Difference Between Semaglutide and Tirzepatide?

Head-to-head body composition data is limited as of 2026. SURMOUNT-1 (tirzepatide) and STEP 1 (semaglutide) had different protocols and populations, so direct comparison is shaky. Tirzepatide produces more total weight loss; the absolute lean mass loss is likely greater on tirzepatide, but the percentage of weight lost as fat appears similar. Most prep coaches default to semaglutide because it has more body-comp data and longer clinical history.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.